Maier Marissa, Beste Lauren A, Lowy Elliott, Hauser Ronald G, Van Epps Puja, Yakovchenko Vera, Rogal Shari, Chartier Maggie, Ross David
Oregon Health & Science University, Division of Infectious Diseases, Department of Medicine; VA Portland Health Care System, Portland, Oregon, USA.
University of Washington, Department of Medicine, VA Puget Sound Health Care System, Seattle, Washington USA.
Open Forum Infect Dis. 2024 Jul 11;11(8):ofae382. doi: 10.1093/ofid/ofae382. eCollection 2024 Aug.
The diagnosis-based Human Immunodeficiency Virus (HIV) Care Continuum offers a well-established framework for measuring HIV care quality. It is used by the government agencies, community organizations, and health care institutions to "guide the nation's response to HIV" and assesses HIV care from the time of HIV diagnosis through viral suppression. Our objective is to present the Veteran Health Administration's (VHA) HIV Care Continuum, assess postpandemic versus prepandemic performance, and compare VHA performance to Centers for Disease Control and Prevention-published data.
We conducted a nationwide retrospective cohort analysis examining the care continuum for people with HIV (PWH) in VHA care in 2019 versus 2022. Measurements included linkage to care, receipt of care, retention in care, and viral suppression. We used multivariable logistic regression of virological suppression to identify factors associated with viral suppression.
In VHA in 2019, 83% of individuals newly diagnosed with HIV were linked to care, 84% of PWH received care, 76% were retained in care, and viral suppression was 76% among those with HIV and 93% of those with viral load (VL) results. In 2022, 74% were linked to care, 79% received care, 67% were retained in care, and viral suppression was 70% among those with HIV and 94% of those with a VL result.
VHA has achieved >90% viral suppression among those with a VL result. Among all PWH, viral suppression decreased an absolute 5.2% between 2019 and 2022. VHA's performance on the HIV Care Continuum exceeds the national HIV Care Continuum reported by the Centers for Disease Control and Prevention.
基于诊断的人类免疫缺陷病毒(HIV)照护连续体为衡量HIV照护质量提供了一个成熟的框架。政府机构、社区组织和医疗机构使用该框架“指导国家应对HIV”,并评估从HIV诊断到病毒抑制阶段的HIV照护情况。我们的目标是展示退伍军人健康管理局(VHA)的HIV照护连续体,评估疫情后与疫情前的表现,并将VHA的表现与疾病控制和预防中心公布的数据进行比较。
我们进行了一项全国性的回顾性队列分析,研究2019年与2022年VHA照护下的HIV感染者(PWH)的照护连续体情况。测量指标包括与照护的联系、接受照护情况、照护留存率和病毒抑制情况。我们使用病毒学抑制的多变量逻辑回归来确定与病毒抑制相关的因素。
2019年在VHA,83%新诊断出HIV的个体与照护建立了联系,84%的PWH接受了照护,76%的人保持在照护中,HIV感染者的病毒抑制率为76%,病毒载量(VL)检测结果者的病毒抑制率为93%。2022年,74%的人与照护建立了联系,79%的人接受了照护,67%的人保持在照护中,HIV感染者的病毒抑制率为70%,VL检测结果者的病毒抑制率为94%。
VHA在有VL检测结果的人群中实现了>90%的病毒抑制率。在所有PWH中,2019年至2022年期间病毒抑制率绝对下降了5.2%。VHA在HIV照护连续体方面的表现超过了疾病控制和预防中心报告的全国HIV照护连续体表现。